Resolution of in flammation: state of the art, definitions and terms
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
A recent focus meeting on Controlling Acute Inflammation was held in London, April 27–28, 2006, organized by D.W. Gilroy and S.D. Brain for the British Pharmacology Society. We concluded at the meeting that a consensus report was needed that addresses the rapid progress in this emerging field and details how the specific study of resolution of acute inflammation provides leads for novel anti‐inflammatory therapeutics, as well as defines the terms and key components of interest in the resolution process within tissues as appreciated today. The inflammatory response protects the body against infection and injury but can itself become dysregulated with deleterious consequences to the host. It is now evident that endogenous biochemical pathways activated during defense reactions can counter‐regulate inflammation and promote resolution. Hence, resolution is an active rather than a passive process, as once believed, which now promises novel approaches for the treatment of inflammation‐associated diseases based on endogenous agonists of resolution.—Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., Wallace, J. L. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325–332 (2007)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The process of inflammation resolution involves not only passive mechanisms, e.g., dissipation of chemotactic gradient or initial danger signals, but also active biochemical pathways [103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · cited 3×
“TLRs and NLRs also sense products of inflamed tissue, and notable examples are the sensing of low MW hyaluronic acid fragments by TLR2 and TLR4 (13) and the sensing of uric acid by Nalp3 (14).”
Background(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552 · cited 2×
“1C), may lead to prolonged inflammation and the inability for the tissue to return to homeostasis (26) and complete the full life-cycle per se of the neutrophils and mononuclear cells recruited to the tissue.”
BackgroundSelf-citationAgostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768 · cited 1×
“Nalp3 occurs in an inflammasome complex with caspase-1, ASC, cardinal, and Nalp2 ( 12 ).”
BackgroundMolecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684 · cited 1×
“Uric acid is the causative agent of gout but is also released by damaged cells, possibly as a general signal for inflammation (15).”
BackgroundSerhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · cited 1×
“Additionally, the widely used aspirin jump-starts resolution by making up for its loss in prostaglandin production, which plays key roles in resolution, by instead generating the epimeric version of lipid mediators (25), such as the aspirin-triggered lipoxins (recently reviewed in ref.”
BackgroundSelf-citationNegative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509 · cited 8×
“In effect, TLRs sow the seeds of their own destruction, and the role of negative regulators clearly indicates how robust the TLR system is.”
BackgroundInfluentialSelf-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · cited 1×
“enzymes are expressed (31), and whether it is resolving”
BackgroundSelf-citationRegulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401 · cited 4×
“TLRs and NLRs also sense products of inflamed tissue, and notable examples are the sensing of low MW hyaluronic acid fragments by TLR2 and TLR4 (13) and the sensing of uric acid by Nalp3 (14).”
BackgroundInfluentialInducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Self-citation
Cited by
Items 201–300 of 1,000
Resolvin E1 Metabolome in Local Inactivation during Inflammation-Resolution
Hong, S., Porter, T. F., Lu, Y., Oh, S. F., Pillai, P. S., & Serhan, C. N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3512 · Cited by 108
“Resolution of acute inflammation and its potential failure may underlie the mechanisms for presenting chronic unresolved inflammation in many diseases (1, 35).”
BackgroundSelf-citationProteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis
Millet, A., Martin, K., Bonnefoy, F., Saas, P., Mocek, J., Alkan, M., Terrier, B., Kerstein-Staehle, A., Tamassia, N., Satyanarayanan, S. K., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78182 · Cited by 113
“This process, known as efferocytosis (16–18), could in turn lead to nonresolving inflammation (19, 20).”
BackgroundMorris, T., Stables, M., Colville-Nash, P., Newson, J., Bellingan, G., de Souza, P. M., & Gilroy, D. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000373107 · Cited by 106
“Acquired dysregulation of these protective processes at the genetic level or by antiinflammatory agents with hitherto unappreciated resolution-toxic properties (19) may cause ongoing inflammation, tissue injury, or chronic inflammation.”
BackgroundSelf-citationBlood Neutrophils Are Reprogrammed in Bronchiectasis
Bedi, P., Davidson, D. J., McHugh, B. J., Rossi, A. G., & Hill, A. T. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2423oc · Cited by 107
Self-citationCells, cytokines and inflammatory bowel disease: a clinical perspective
Roberts‐Thomson, I. C., Fon, J., Uylaki, W., Cummins, A. G., & Barry, S. C. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.74 · Cited by 124
H2S-releasing drugs: Anti-inflammatory, cytoprotective and chemopreventative potential
Gemici, B., Elsheikh, W., Feitosa, K. B., Costa, S. K. P., Muscará, M. N., & Wallace, J. L. (2014) · Nitric Oxide · doi:10.1016/j.niox.2014.11.010 · Cited by 110
Self-citationDalli, J., Consalvo, A. P., Ray, V., Di Filippo, C., D’Amico, M., Mehta, N., & Perretti, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203000 · Cited by 103
“A cute inflammation represents a protective process mounted by the host in response to tissue damage and/or pathogenic infection (1, 2).”
BackgroundSelf-citationMacrophage immunomodulation in chronic osteolytic diseases—the case of periodontitis
Sima, C., Viniegra, A., & Glogauer, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ru0818-310r · Cited by 114
Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases
Abdolmaleki, F., Kovanen, P. T., Mardani, R., Hayat, S. M. G., Bo, S., & Sahebkar, A. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08754-9 · Cited by 117
“to the failure of inflammation resolution [6].”
BackgroundMa, D., Zhao, Y., Huang, L., Xiao, Z., Chen, B., Shi, Y., Shen, H., & Dai, J. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119830 · Cited by 107
Candida albicans Modulates Host Defense by Biosynthesizing the Pro-Resolving Mediator Resolvin E1
Haas-Stapleton, E. J., Lu, Y., Hong, S., Arita, M., Favoreto, S., Nigam, S., Serhan, C. N., & Agabian, N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001316 · Cited by 103
“glandins promote or resolve inflammation [1,2,3] while in plants,”
BackgroundSelf-citationResolution of ulcerative colitis
Neurath, M. F., & Leppkes, M. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00751-6 · Cited by 112
Huang, C.-W., Chien, Y.-S., Chen, Y.-J., Ajuwon, K., Mersmann, H., & Ding, S.-T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101689 · Cited by 100
“, RvE1, RvE2 and RvE3) are produced from EPA, and DHA is a precursor of three distinct specialized pro-resolving lipid mediators (SPM) that include the D-series resolvins, protectins and aresins [61].”
BackgroundNavarro-Xavier, R. A., Newson, J., Silveira, V. L. F., Farrow, S. N., Gilroy, D. W., & Bystrom, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902866 · Cited by 100
“Indeed, it would also give some insight into molecules that exert so-called resolution-toxic effects (3), because molecules that unwittingly impair resolution may be highlighted more readily than if the model with 10 mg of zymosan is used.”
BackgroundSelf-citationRole of Neutrophil Apoptosis in the Resolution of Inflammation
Kebir, D. E., & Filep, J. G. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.169 · Cited by 115
“An important recent advance is the discovery that resolution of inflammation involves tightly controlled, active resolution programs[1,2].”
BackgroundInfluentialVago, J. P., Tavares, L. P., Garcia, C. C., Lima, K. M., Perucci, L. O., Vieira, É. L. M., Nogueira, C. R. C., Soriani, F. M., Martins, J. O., Silva, P., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401722 · Cited by 106
Kang, J., & Lee, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.06.002 · Cited by 108
Francos-Quijorna, I., Sánchez-Petidier, M., Burnside, E. R., Badea, S. R., Espin, A. T., Marshall, L., de Winter, F., Verhaagen, J., Moreno‐Manzano, V., & Bradbury, E. J. (2022) · Nature Communications · doi:10.1038/s41467-022-30467-5 · Cited by 111
Wang, S. B., Hu, K. M., Seamon, K. J., Mani, V., Chen, Y., & Gronert, K. (2012) · The FASEB Journal · doi:10.1096/fj.11-198036 · Cited by 96
“Specific eicosanoid circuits, such as the lipoxin A4 (LXA4) and 15-lipoxygenase (15-LOX) circuit, have emerged as key mediators of inflammatory resolution and anti-inflammation (18, 21).”
BackgroundTargeted Metabolomic Analysis of Serum Fatty Acids for the Prediction of Autoimmune Diseases
Tsoukalas, D., Fragoulakis, V., Sarandi, E., Docea, A. O., Papakonstaninou, E., Tsilimidos, G., Anamaterou, C., Fragkiadaki, P., Aschner, M., Tsatsakis, A., et al. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00120 · Cited by 95
“Total fatty acids (TFAs) are valuable markers of inflammation and gain increasing attention in cases of chronic inflammation as in ADs (Serhan et al., 2007).”
BackgroundWeissmüller, T., Campbell, E. L., Rosenberger, P., Scully, M. M., Beck, P. L., Furuta, G. T., & Colgan, S. P. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35874 · Cited by 96
“It is now appreciated that during ongoing inflammation, infiltrating leukocytes can significantly influence tissue function through the liberation of soluble mediators and thus can promote the resolution of inflammation (5).”
BackgroundConfronting an influenza pandemic with inexpensive generic agents: can it be done?
Fedson, D. S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70070-7 · Cited by 94
Rabinovich, G. A., & Ilarregui, J. M. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00787.x · Cited by 92
“Resolution of acute inflammation involves the activation of endogenous biochemical programs and key regulatory components that enable inflamed tissues to return to homeostasis (140).”
BackgroundHellmann, J., Zhang, M. J., Tang, Y., Rane, M., Bhatnagar, A., & Spite, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203369 · Cited by 93
“In addition to defective macrophage phagocytosis, altered resolution of inflammation could also be due to prolongation of PMN survival (22, 28, 29).”
BackgroundTabas, I. A. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308036 · Cited by 100
Feng, X., Deng, T., Zhang, Y., Su, S., Wei, C., & Han, D. (2011) · Immunology · doi:10.1111/j.1365-2567.2010.03364.x · Cited by 92
Marceca, G. P., Londhe, P., & Calore, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00298 · Cited by 93
“However, inappropriate accumulation/regulation of leukocytes in the tumor site can cause an imbalance between pro- and anti-inflammatory mechanisms, eventually leading to chronic inflammation and subsequent immunosuppression (30), as occurs in advanced cancer patients.”
BackgroundEicosanoids in Metabolic Syndrome
Hardwick, J. P., Eckman, K., Lee, Y., Abdelmegeed, M. A., Esterle, A. R., Chilian, W. M., Chiang, J. Y. L., & Song, B. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-404717-4.00005-6 · Cited by 105
“Although the pathophysiological role of LXA4 and LX receptor is suggested, their role in human disease has at best been a causal association (Serhan et al., 2007) and thus their role in MetS and NAFLD has not been investigated.”
BackgroundControl of inflammation and periodontitis
Dyke, T. E. V. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2007.00229.x · Cited by 110
Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation
Odusanwo, O., Chinthamani, S., McCall, A. D., Duffey, M. E., & Baker, O. J. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00207.2011 · Cited by 96
Resolution-associated molecular patterns (RAMP): RAMParts defending immunological homeostasis?
Shields, A. M., Panayi, G. S., & Corrigall, V. M. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04433.x · Cited by 90
Neutrophil apoptosis: A target for enhancing the resolution of inflammation
Filep, J. G., & Kebir, D. E. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22351 · Cited by 105
“JOURNAL OF CELLULAR BIOCHEMISTRY NEUTROPHIL APOPTOSIS IN INFLAMMATION 1041 stimulate activation and recruitment of monocytes/macrophages and inhibit neutrophil activation, chemotaxis, adhesion, transmigration, and tissue accumulation [Serhan et al., 2007, 2008].”
BackgroundReparative T lymphocytes in organ injury
D’Alessio, F. R., Kurzhagen, J. T., & Rabb, H. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124614 · Cited by 89
“Moreover, a timely resolution of inflammation is required for repair (2).”
BackgroundResolving inflammation by TAM receptor activation
Vago, J. P., Amaral, F. A., & van de Loo, F. A. J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107893 · Cited by 95
Endogenous lipid mediators in the resolution of airway inflammation
Haworth, O., & Levy, B. D. (2007) · European Respiratory Journal · doi:10.1183/09031936.00005807 · Cited by 88
Mohamed, I. N., Ishrat, T., Fagan, S. C., & El-Remessy, A. B. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6126 · Cited by 88
Vong, L., Ferraz, J. G., Panaccione, R., Beck, P. L., & Wallace, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004982107 · Cited by 87
“During this process, mediators are released that can modulate cytokine and chemokine levels and regulate leukocyte and monocyte trafficking (4, 5).”
BackgroundSelf-citationLeitch, A. E., Riley, N. A., Sheldrake, T. A., Festa, M., Fox, S., Duffin, R., Haslett, C., & Rossi, A. G. (2010) · European Journal of Immunology · doi:10.1002/eji.200939664 · Cited by 90
Self-citationChistyakov, D. V., Astakhova, A. A., Azbukina, N. V., Goriainov, S. V., Chistyakov, V. V., & Sergeeva, M. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163894 · Cited by 86
“Oxylipins have tremendous effects on cellular responses, including pro- and anti- inflammatory actions via specialized plasma membrane receptors, nuclear receptors or other mechanisms [23,24].”
Regulation of Neutrophil Survival/Apoptosis by Mcl-1
Milot, É., & Filep, J. G. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/131539 · Cited by 98
“Efficient resolution of inflammation therefore relies on inhibition of neutrophil influx, recruitment of monocytes, rapid clearance of infiltrating neutrophils, and regeneration of damaged tissue structures [14, 15].”
Prostaglandin and the Suppression of Phagocyte Innate Immune Responses in Different Organs
de Medeiros, A. I., Peres‐Buzalaf, C., Verdan, F. F., & Serezani, C. H. (2012) · Mediators of Inflammation · doi:10.1155/2012/327568 · Cited by 101
“The anti-inflammatory response opposes the host inflammatory response, which potentially limits collateral damage to neighboring cells and tissues and aids in the resolution of inflammation after the pathogens are contained [11].”
BackgroundTissue stroma as a regulator of leukocyte recruitment in inflammation
McGettrick, H. M., Butler, L. M., Buckley, C. D., Rainger, G. E., & Nash, G. B. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0911458 · Cited by 94
“[2]).”
Self-citationMoro, K., Nagahashi, M., Ramanathan, R., Takabe, K., & Wakai, T. (2016) · World Journal of Clinical Cases · doi:10.12998/wjcc.v4.i7.155 · Cited by 101
Halade, G. V., Kain, V., Black, L. M., Prabhu, S. D., & Ingle, K. A. (2016) · Aging · doi:10.18632/aging.101077 · Cited by 84
Biased perspectives on formyl peptide receptors
Raabe, C. A., Gröper, J., & Rescher, U. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.11.015 · Cited by 90
EPA- and DHA-derived resolvins' actions in inflammatory bowel disease
Schwanke, R. C., Marcon, R., Bento, A. F., & Calixto, J. Β. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.050 · Cited by 89
“The lipid mediators derived from EPA and DHA (Koduri et al., 2014) RvD1, RvD2, RvE1, and RvE2, protectin D1 and more recently maresins were first characterised by Serhan et al. (Bannenberg and Serhan, 2010; Serhan, 2010; Serhan et al., 2007; Serhan et al., 2008; Serhan and Savill, 2005).”
BackgroundLipoxin and resolvin biosynthesis is dependent on 5‐lipoxygenase activating protein
Lehmann, C., Homann, J., Ball, A., Blöcher, R., Kleinschmidt, T. K., Basavarajappa, D. K., Angioni, C., Ferreirós, N., Häfner, A., Rådmark, O., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-275487 · Cited by 84
“In the past, cessation of inflammation has been considered a passive phenomenon in which the effector cells and the proinflammatory mediators are gradually washed out from the inflamed site (1).”
Background[Inflammation and obesity (lipoinflammation)].
Izaola, O., de Luis, D. A., Sajoux, I., Domingo, J. C., & Vidal, M. (2015) · PubMed · doi:10.3305/nh.2015.31.6.8829 · Cited by 83
Endogenous galectins and the control of the host inflammatory response
Norling, L. V., Perretti, M., & Cooper, D. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0512 · Cited by 90
“…mediators exist to initiate inflammation, a repertoire of anti-inflammatory mediators and mechanisms operate in the host to promote and control the phase of resolution, by inhibiting leukocyte migration and promoting clearance of inflammatory cells (Gilroy, et al. 2004; Serhan, et al. 2007).”
Self-citationMathematical Modelling of Immune Response in Tissues
Su, B., Zhou, W., Dorman, K. S., & Jones, D. E. (2008) · Computational and Mathematical Methods in Medicine · doi:10.1080/17486700801982713 · Cited by 99
“These two cell types now arrive simultaneously, in disagreement with the known temporal order for immune cell recruitment to granuloma [64].”
BackgroundRoss, E. A., Naylor, A. J., O’Neil, J. D., Crowley, T., Ridley, M. L., Crowe, J., Smallie, T., Tang, T., Turner, J. D., Norling, L. V., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209424 · Cited by 83
Self-citationTargeting chronic inflammation as a potential adjuvant therapy for osteoporosis
Livshits, G., & Kalinkovich, A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120847 · Cited by 88
Spite, M., Summers, L., Porter, T., Srivastava, S., Bhatnagar, A., & Serhan, C. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00234.x · Cited by 82
“The development and resolution of inflammation are governed, in part, by temporally and spatially regulated formation and action of enzymatically derived lipid mediators (Serhan et al., 2007a).”
BackgroundMethodSelf-citationPathways mediating resolution of inflammation: when enough is too much
Fullerton, J. N., O'Brien, A. J., & Gilroy, D. W. (2013) · The Journal of Pathology · doi:10.1002/path.4232 · Cited by 96
Self-citationThe Melanocortin Agonist AP214 Exerts Anti-Inflammatory and Proresolving Properties
Montero‐Melendez, T., Patel, H., Seed, M. P., Nielsen, S. D.-H., Jonassen, T. E. N., & Perretti, M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.042 · Cited by 83
“Once we had studied the anti-inflammatory properties of AP214, we sought to use this compound to explore novel activities related to the resolution of inflammation, an emerging field that has witnessed rapid progress in the past few years.(1,27) Resolution is an active process consisting of the activation of endogenou…”
BackgroundSelf-citationLucas, C. D., Dorward, D. A., Tait, M., Fox, S., Marwick, J. A., Allen, K. C., Robb, C. T., Hirani, N., Haslett, C., Duffin, R., et al. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.102 · Cited by 88
“Following successful control of tissue injury and/or infection, neutrophil function must be terminated in a timely manner to prevent neutrophilmediated host tissue damage.(3,4) This is achieved by the highly regulated events of neutrophil apoptosis and subsequent uptake and removal of apoptotic neutrophils by surround…”
BackgroundInfluentialSelf-citationLi, D., Hodges, R. R., Jiao, J., Carozza, R. B., Shatos, M. A., Chiang, N., Serhan, C. N., & Dartt, D. A. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.7 · Cited by 81
Self-citationThe impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis
Patel, H., Kornerup, K. N., Sampaio, A. L. F., D’Acquisto, F., Seed, M. P., Girol, A. P., Gray, M., Pitzalis, C., Oliani, S. M., & Perretti, M. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201180 · Cited by 89
Self-citationPKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation
Kong, D., Shen, Y., Liu, G., Zuo, S., Ji, Y., Lu, A., Nakamura, M., Lazarus, M., Stratakis, C. A., Breyer, R. M., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160459 · Cited by 81
“Monocyte/macrophage infiltration is critical for inflammatory resolution (Serhan et al., 2007) and MI recovery (Ben-Mordechai et al., 2015).”
BackgroundKrüger, K., Reichel, T., & Zeilinger, C. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01052.2018 · Cited by 90
Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response
Rosenbaum, P., Tchitchek, N., Joly, C., Pozo, A. R., Stimmer, L., Langlois, S., Hocini, H., Gosse, L., Pejoski, D., Cosma, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.645210 · Cited by 91
“This could result in a better capacity to rapidly resolve the local inflammation induced by MVA (58) or conversely augment Ag presentation and the initiation of adaptive immunity.”
Yoon, Y. M., Lewis, J. S., Carstens, M. R., Campbell‐Thompson, M., Wasserfall, C. H., Atkinson, M. A., & Keselowsky, B. G. (2015) · Scientific Reports · doi:10.1038/srep13155 · Cited by 85
Negreiros-Lima, G. L., Lima, K. M., Moreira, I. Z., Jardim, B. L. O., Vago, J. P., Galvão, I., Teixeira, L. C. R., Pinho, V., Teixeira, M. M., Sugimoto, M. A., et al. (2020) · Cells · doi:10.3390/cells9010128 · Cited by 89
Yacoubian, S., & Serhan, C. N. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0616 · Cited by 87
“This temporal switch to proresolving mediators during the evolution of a local inflammatory response seems to be essential for complete resolution and the return to homeostasis”
BackgroundSelf-citationMesenchymal Stem Cell-Like Properties in Fibroblasts
Chang, Y., Li, H., & Guo, Z. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000363035 · Cited by 80
Terrando, N., Yang, T., Ryu, J. K., Newton, P. T., Monaco, C., Feldmann, M., Ma, D., Akassoglou, K., & Maze, M. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00143 · Cited by 80
Inflammation: cytokines and RNA‐based regulation
Stumpo, D. J., Lai, W. S., & Blackshear, P. J. (2010) · WIREs RNA · doi:10.1002/wrna.1 · Cited by 79
Chiu, C., Gomolka, B., Dierkes, C., Huang, N. R., Schroeder, M., Purschke, M., Manstein, D., Dangi, B., & Weylandt, K. H. (2012) · Inflammation Research · doi:10.1007/s00011-012-0489-8 · Cited by 85
“Recent findings indicate that, in the process of inflammation resolution, endogenous mediators are released to promote tissue healing and to protect from inflammation spiralling out of control [1].”
Anti-inflammatory and Cytoprotective Properties of Hydrogen Sulfide
Gemici, B., & Wallace, J. L. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2014.11.034 · Cited by 87
“Annexin-1 is contained within neutrophils and is released during inflammatory reactions as part of the process of induction appropriate resolution of inflammation (Perretti & D’Acquisto, 2009; Serhan et al., 2007; Vong et al., 2007).”
Self-citationAnti-Inflammatory Nutrition as a Pharmacological Approach to Treat Obesity
Sears, B., & Ricordi, C. (2011) · Journal of Obesity · doi:10.1155/2011/431985 · Cited by 78
“Today we know the inflammatory process is a complex interaction of both the pro- and anti-inflammatory phases [5, 6].”
BackgroundProstanoids and Resolution of Inflammation – Beyond the Lipid-Mediator Class Switch
Schmid, T., & Brüne, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714042 · Cited by 89
Chen, H., Wu, X., Xu, C., Lin, J., & Liu, Z. (2021) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbab025 · Cited by 83
López-Castejón, G., Baroja-Mazo, A., & Pelegrı́n, P. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0609-y · Cited by 85
“Inflammation is characterized by an initial influx of polymorphonuclear leukocytes followed by monocytederived macrophages, finishing with the resolution phase after normal tissue homeostasis has been restored [9–11].”
BackgroundMori, T. A. (2014) · Food & Function · doi:10.1039/c4fo00393d · Cited by 91
Newson, J., Motwani, M. P., Kendall, A. C., Nicolaou, A., Muccioli, G. G., Alhouayek, M., Bennett, M., Van De Merwe, R., James, S., De Maeyer, R. P. H., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.098 · Cited by 77
“Until now, there was the view that homeostasis is restored once acute inflammation resolves (Serhan et al., 2007).”
BackgroundSelf-citationZhao, X., Zhao, Y., Qin, X., Wan, L.-Y., & Fan, X. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1227-7 · Cited by 76
Tulotta, C., Stefanescu, C., Chen, Q., Torraca, V., Meijer, A. H., & Snaar-Jagalska, E. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-38643-2 · Cited by 77
Doxycycline for Alzheimer’s Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
Balducci, C., & Forloni, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00738 · Cited by 76
Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease
Fu, T., Mohan, M., Brennan, E. P., Woodman, O. L., Godson, C., Kantharidis, P., Ritchie, R. H., & Qin, C. X. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00097 · Cited by 83
Defining the phenotype of neutrophils following reverse migration in zebrafish
Ellett, F., Elks, P. M., Robertson, A. L., Ogryzko, N. V., & Renshaw, S. A. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ma0315-105r · Cited by 76
“Failure of inflammation resolution underlies the pathology of many chronic diseases, including atherosclerosis, rheumatoid arthritis, osteoporosis, and chronic obstructive pulmonary disease [1].”
BackgroundTian, H., Lu, Y., Sherwood, A. M., Hongqian, D., & Hong, S. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3146 · Cited by 76
“Leukocyte infiltration and activation are the key events of inflammation and the consequent pathologic conditions.(3) It is well known that leukocytes adhere to, roll along, and infiltrate the endothelial wall of blood vessels during inflammation.”
BackgroundCavalcanti, D. M. D. H., Lotufo, C. M. C., Borelli, P., Ferreira, Z. S., Markus, R. P., & Farsky, S. H. P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707512 · Cited by 76
“Results from recent studies have led to the awareness that endogenous biochemical routes must be promptly activated to defend the host and then inactivated when resolution is achieved (Serhan et al., 2007).”
BackgroundMarine Diterpenoids as Potential Anti‐Inflammatory Agents
González, Y., Torres‐Mendoza, D., Jones, G. E., & Fernández, P. L. (2015) · Mediators of Inflammation · doi:10.1155/2015/263543 · Cited by 82
“, cytokines, chemokines, and free radicals), which amplify the response [2].”
Motwani, M. P., Bennett, F., Norris, P. C., Maini, A. A. N., George, M. J., Newson, J., Henderson, A., Hobbs, A. J., Tepper, M. A., White, B., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.980 · Cited by 80
Self-citationImmuno-modulation and anti-inflammatory benefits of antibiotics: the example of tilmicosin.
Buret, A. G. (2010) · Europe PMC (PubMed Central) · Cited by 106
Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells
Markworth, J. F., Brown, L. A., Lim, E. Y., Floyd, C., Larouche, J. A., Castor‐Macias, J. A., Sugg, K. B., Sarver, D. C., Macpherson, P. C. D., Davis, C. S., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137713 · Cited by 85
Dietary n-3 PUFA and CVD: a review of the evidence
Mori, T. A. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003583 · Cited by 86
Motwani, M. P., Colas, R. A., George, M. J., Flint, J., Dalli, J., Richard-Loendt, A., Maeyer, R. P. H. D., Serhan, C. N., & Gilroy, D. W. (2018) · JCI Insight · doi:10.1172/jci.insight.94463 · Cited by 76
“to identify novel internal counterregulatory systems that terminate inflammation in order to provide new targets that can be manipulated pharmacologically to push ongoing inflammation down a proresolution pathway (9).”
BackgroundSelf-citationFlavones induce neutrophil apoptosis by down‐regulation of Mcl‐1 via a proteasomal‐dependent pathway
Lucas, C. D., Allen, K. C., Dorward, D. A., Hoodless, L. J., Melrose, L. A., Marwick, J. A., Tucker, C. S., Haslett, C., Duffin, R., & Rossi, A. G. (2012) · The FASEB Journal · doi:10.1096/fj.12-218990 · Cited by 79
“Nevertheless, once an episode of acute neutrophilic inflammation is complete, it is essential that neutrophil recruitment is halted and that recruited neutrophils undergo apoptosis, before disposal of the apoptotic cells by surrounding phagocytes such as macrophages, to ensure efficient resolution of inflammation (3).”
BackgroundSelf-citationKoltsida, O., Karamnov, S., Pyrillou, K., Vickery, T., Chairakaki, A., Tamvakopoulos, C., Sideras, P., Serhan, C. N., & Andreakos, E. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201891 · Cited by 72
“We found significant increases in 7-hydroxydocosahexaenoic acid (d5-7-HDHA), d5-14-HDHA and d5-17-HDHA (Fig 5), rate-limiting components in the metabolism of DHA to its bioactive derivatives (Hong et al, 2003; Miyata et al, 2013; Serhan et al, 2006).”
Self-citationSurgical inflammation: a pathophysiological rainbow
Arias, J. I., Aller, M., & Árias, J. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-19 · Cited by 82
“The pro-inflammatory mechanisms are counterbalanced by endogenous antiinflammatory signals, that serve to temper the severity and limit the duration of the early phases, which leads to their resolution [83,86,87].”
BackgroundInfluentialRelevance of granulocyte apoptosis to resolution of inflammation at the respiratory mucosa
Leitch, A. E., Duffin, R., Haslett, C., & Rossi, A. G. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.31 · Cited by 73
Self-citationRamos, G. C., Fernandes, D., Charão, C. C. T., Souza, D. G., Teixeira, M. M., & Assreuy, J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707302 · Cited by 73
“, 1998; Aramaki, 2000), few studies have addressed this question in vivo (Huynh et al., 2002; Hoffmann et al., 2005; Pinho et al., 2005; Rossi et al., 2006; Sawatzky et al., 2006; Serhan et al., 2007).”
BackgroundInfluentialCash, J. L., Bass, M. D., Campbell, J., Barnes, M., Kubes, P., & Martin, P. (2014) · Current Biology · doi:10.1016/j.cub.2014.05.006 · Cited by 71
“Resolution mediators function to dampen the inflammatory response and promote its resolution [5, 10]; however, their potential role in the context of dermal wound repair has, surprisingly, barely been investigated.”
Annexin A1 promotes timely resolution of inflammation in murine gout
Galvão, I., Vago, J. P., Barroso, L. C., Tavares, L. P., Queiroz‐Junior, C. M., Costa, V. V., Carneiro, F. S., Ferreira, T. P. T., Silva, P., Amaral, F. A., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201646551 · Cited by 78
Zampieri, R. M., Adessi, A., Caldara, F., Codato, A., Furlan, M., Rampazzo, C., Philippis, R. D., Rocca, N. L., & Valle, L. D. (2020) · Biomolecules · doi:10.3390/biom10040582 · Cited by 82
Lou, D., Luo, Y., Pang, Q., Tan, W., & Ma, L. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.04.018 · Cited by 82
Emre, C., Do, K. V., Jun, B., Hjorth, E., Alcalde, S. G., Kautzmann, M.-A. I., Gordon, W. C., Nilsson, P., Bazan, N. G., & Schultzberg, M. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01216-4 · Cited by 70
“At the same time, anti-inflammatory cytokine expression is up-regulated and non-phlogistic phagocytosis modulated [77, 85].”
BackgroundProresolving lipid mediators: potential for prevention and treatment of periodontitis
Dyke, T. E. V. (2011) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2010.01662.x · Cited by 81
Flesher, R. P., Herbert, C. A., & Kumar, R. K. (2013) · Clinical Science · doi:10.1042/cs20130623 · Cited by 71
Metadata
- Authors
- Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L.
- Affiliations
- Brigham and Women's Hospital (US)
- King's College London (GB)
- University of Birmingham (GB)
- University College London (GB)
- Centre for Inflammation Research (GB)
- Trinity College Dublin (IE)
- Queen Mary University of London (GB)
- University of Calgary (CA)
- Corresponding author
- Serhan, Charles N.
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-02
- Volume
- 21
- Issue
- 2
- Pages
- 325-332
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3119634
- OpenAlex
- W2120699390
- Cited by
- 1,045
- References
- 36
- Citations by year
- 2026: 20 · 2025: 26 · 2024: 30 · 2023: 46 · 2022: 42 · 2021: 59 · 2020: 70 · 2019: 53 · 2018: 57 · 2017: 59 · 2016: 57 · 2015: 66 · 2014: 65 · 2013: 90 · 2012: 74
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Norges Idrettshøgskole
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- inflammation resolution, acute inflammation, anti-inflammatory agents, inflammation-associated diseases
- MeSH terms
- Animals, Anti-Inflammatory Agents, Humans, Inflammation, Leukocytes, Models, Biological, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.